SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glenmark out-licences pain molecule to Sanofi

04 May 2010 Evaluate

Drug-maker Glenmark has formalised an outlicensing deal with Sanofi-aventis to further develop and commercialise the former's novel agents to treat chronic pain, including prospective pain molecule GRC 15300.

 

The deal breaks a drought of close to two-and-a-half years on the outlicensing front, besides marking a turnaround on the research front for the company. Glenmark will receive an upfront payment of $ 20 million from the Sanofi deal, with milestone and 'double-digit' royalty payments as the molecule is further developed and hits the market. The total value of these payments is pegged at $325 million.

 

The deal outlines exclusive marketing rights for Sanofi in North America, European Union and Japan, subject to Glenmark's right to co-promote the products in the US and five Eastern European countries. Sanofi-Aventis will also have co-marketing rights in 10 other countries including Brazil, Russia, and China, while Glenmark will retain exclusive rights in India and other countries of the rest of the world.

crackcrack

Glenmark Pharma Share Price

2247.90 -1.65 (-0.07%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×